You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORKA Exercise Disclosure
Agarwal Arjun · SEC Form 4 · Filed Oct 13, 2026
Exercise
Calculated transaction value
$0
Agarwal Arjun Senior Vice President, Finance
ORKA
Oruka Therapeutics
ORKA
Transaction date
Oct 12, 2026
Public filing date
Oct 13, 2026
Filing lag
Filed 1 day later
ORKA daily price context
Close on/before transaction
$80.35
Oct 12, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (right to buy) on Common Stock
- Quantity / price
- 8,541 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0000907654-26-000106
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$962.79K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA | Sale | Oct 12, 2026 | $160.27K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Oct 12, 2026 | $0 |
| Oruka Therapeutics, Inc. ORKA | Exercise | Oct 12, 2026 | $106.76K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Oct 12, 2026 | $50.14K |
| Oruka Therapeutics, Inc. ORKA | Sale | Oct 12, 2026 | $459.45K |
| Oruka Therapeutics, Inc. ORKA | Sale | Oct 12, 2026 | $16.57K |
| Oruka Therapeutics, Inc. ORKA Current | Exercise | Oct 12, 2026 | $0 |
| Oruka Therapeutics, Inc. ORKA | Sale | Oct 12, 2026 | $169.6K |